Diagnosis Code

T50.905D ADVERSE EFFECT OF UNSP DRUG/MEDS/BIOL SUBST, SUBS


Code Information

Diagnosis Code: T50.905D

Short Description: Adverse effect of unsp drug/meds/biol subst, subs

Long Description: Adverse effect of unspecified drugs, medicaments and biological substances, subsequent encounter

The code T50.905D is VALID for claim submission

Code Classification:

  • Injury, poisoning and certain other consequences of external causes (S00–T88)
    • Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50)
      • Diuretics and oth and unsp drug/meds/biol subst (T50)
        • T50.905D Adverse effect of unsp drug/meds/biol subst, subs

Code Version: 2022 ICD-10-CM


Synonyms

  • Abnormal drug tolerance
  • Abnormal hormone secretion
  • Abnormal movement
  • Abnormality of secretion of gastrin
  • Acanthosis nigricans
  • Acneiform drug eruption
  • Acneiform eruption
  • Acquired acanthosis nigricans
  • Acquired central hypothyroidism
  • Acquired coagulation factor inhibitor disorder
  • Acquired coagulation factor inhibitor disorder
  • Acquired coagulation factor inhibitor disorder
  • Acquired coagulation factor inhibitor disorder
  • Acquired epidermolysis bullosa
  • Acquired long QT syndrome
  • Acquired thrombotic thrombocytopenic purpura
  • Acute akathisia caused by drug
  • Acute drug-induced gout
  • Acute drug-induced interstitial lung disorder
  • Acute drug-induced tubulointerstitial nephritis
  • Acute drug-induced ulcer of stomach
  • Acute drug-induced ulcer of stomach
  • Acute edema
  • Acute erythema
  • Acute erythema
  • Acute erythema
  • Acute erythematous eruption of skin
  • Acute erythematous eruption of skin
  • Acute erythematous eruption of skin
  • Acute febrile neutrophilic dermatosis
  • Acute gastric erosion associated with drug ingestion
  • Acute gout
  • Acute hepatic failure
  • Acute hepatic failure due to drugs
  • Acute pulmonary edema
  • Acute tubulointerstitial nephritis
  • Adverse cutaneous reaction to volatile oil
  • Adverse drug interaction
  • Adverse drug interaction
  • Adverse drug interaction
  • Adverse drug interaction
  • Adverse drug interaction
  • Adverse drug interaction
  • Adverse drug interaction with dietary supplement
  • Adverse drug interaction with herbal supplement
  • Adverse drug interaction with over-the-counter medication
  • Adverse drug interaction with prescription medication
  • Adverse drug interaction with tobacco
  • Adverse medication interaction with medication
  • Adverse medication interaction with medication
  • Adverse medication interaction with medication
  • Adverse reaction following injection of substance
  • Adverse reaction following injection of substance
  • Adverse reaction to biological substance
  • Adverse reaction to drug
  • Adverse reaction to lipotropic drugs
  • Adverse reaction to oil
  • Adverse reaction to pharmaceutical excipient
  • Adverse reaction to substance applied to neonatal skin
  • Akathisia
  • Akathisia
  • Akathisia caused by drug
  • Allergic contact dermatitis due to drug in contact with skin
  • Allergic disorder monitoring status
  • Allergic hepatitis
  • Allergic reaction after allergen immunotherapy
  • Allergic reaction after allergen immunotherapy
  • Allergic reaction due to allergy skin test
  • Allergic reaction to colophony
  • Allergic reaction to drug
  • Allergic sensitization
  • Allergic sensitization by patch test
  • Allergy drug side effect
  • Anagen effluvium
  • Anagen effluvium caused by drug
  • Anaphylaxis after allergen immunotherapy
  • Anastomotic ulcer of stomach caused by drug
  • Androgen excess caused by drug
  • Androgen level above reference range
  • Anemia due to medication
  • Annular erythema
  • Annular erythema due to drug
  • Aplasia cutis congenita due to teratogenic drug
  • Aseptic meningitis
  • Aseptic meningitis due to drug
  • Aseptic peritonitis
  • Atrophy of skin due to drug
  • Atrophy of skin due to drug
  • Atypical fracture of femur
  • Autoimmune bullous dermatosis due to drug
  • Autoimmune bullous dermatosis due to drug
  • Autoimmune bullous dermatosis due to drug
  • Autoimmune bullous dermatosis due to drug
  • Autoimmune bullous dermatosis due to drug
  • Autonomic neuropathy due to diabetes mellitus
  • Autonomic neuropathy due to drug induced diabetes mellitus
  • Autonomic neuropathy due to medication induced hypoglycemia
  • Azoospermia due to drug
  • B cell lymphocyte aplasia caused by drug
  • B-cell pseudolymphoma due to drug
  • Benign intracranial hypertension
  • Benign intracranial hypertension due to drug
  • Benign mucous membrane pemphigoid
  • Bilateral cataract of eyes caused by drug
  • Bilateral glaucoma of eyes caused by drug
  • Bilateral keratopathy caused by drug
  • Bilateral open-angle glaucoma
  • Bilateral osteonecrosis of femurs caused by drug
  • Blistering of skin due to drug-induced coma
  • Blistering of skin due to drug-induced coma
  • Blood disorder monitoring status
  • Blood drug side effect
  • Bronchospasm
  • Bronchospasm caused by drug
  • Bullae and sweat gland necrosis in drug-induced coma
  • Bullous dermatosis precipitated by drug treatment
  • Bullous dermatosis precipitated by drug treatment
  • Bullous dermatosis precipitated by drug treatment
  • Bullous dermatosis precipitated by drug treatment
  • Bullous dermatosis precipitated by drug treatment
  • Bullous pemphigoid
  • Capillaritis due to drug
  • Cardiomyopathy caused by drug
  • Cataract due to diabetes mellitus
  • Cataract due to drug induced diabetes mellitus
  • Central hypothyroidism
  • Central nervous system depression
  • Central sleep apnea syndrome
  • Cheilitis medicamentosa
  • Chemical peritonitis
  • Cholangiohepatitis
  • Cholestatic hepatitis
  • Cholestatic jaundice caused by drug
  • Cholestatic jaundice syndrome
  • Chorea due to tardive dyskinesia
  • Chronic bilateral vestibulopathy caused by ototoxic agent
  • Chronic cicatrizing conjunctivitis caused by drug
  • Chronic disease - drug side effects
  • Chronic drug-induced interstitial lung disorders
  • Chronic drug-induced renal disease
  • Chronic drug-induced tubulointerstitial nephritis
  • Chronic drug-induced ulcer of stomach
  • Chronic follicular conjunctivitis due to drug
  • Chronic gout caused by drug
  • Chronic gout of ankle and/or foot without tophus caused by drug
  • Chronic gout of elbow without tophus caused by drug
  • Chronic gout of hand without tophus caused by drug
  • Chronic gout of hip without tophus caused by drug
  • Chronic gout of knee without tophus caused by drug
  • Chronic gout of multiple sites without tophus caused by drug
  • Chronic gout of shoulder without tophus caused by drug
  • Chronic gout of vertebra without tophus caused by drug
  • Chronic gout of wrist without tophus caused by drug
  • Chronic gout without tophus caused by drug
  • Chronic gout without tophus caused by drug
  • Chronic gout without tophus caused by drug
  • Chronic gout without tophus caused by drug
  • Chronic gout without tophus caused by drug
  • Chronic gout without tophus caused by drug
  • Chronic gout without tophus caused by drug
  • Chronic gout without tophus caused by drug
  • Chronic gout without tophus caused by drug
  • Chronic gout without tophus caused by drug
  • Chronic kidney disease stage 1
  • Chronic kidney disease stage 1 due to drug induced diabetes mellitus
  • Chronic kidney disease stage 2
  • Chronic kidney disease stage 2 due to drug induced diabetes mellitus
  • Chronic kidney disease stage 3 due to drug induced diabetes mellitus
  • Chronic kidney disease stage 4
  • Chronic kidney disease stage 4 due to drug induced diabetes mellitus
  • Chronic kidney disease stage 5 due to drug induced diabetes mellitus
  • Chronic tophaceous gout caused by drug
  • Chronic tophaceous gout caused by drug
  • Chronic tophaceous gout caused by drug
  • Chronic tophaceous gout caused by drug
  • Chronic tophaceous gout caused by drug
  • Chronic tophaceous gout caused by drug
  • Chronic tophaceous gout caused by drug
  • Chronic tophaceous gout caused by drug
  • Chronic tophaceous gout caused by drug
  • Chronic tophaceous gout of ankle and/or foot caused by drug
  • Chronic tophaceous gout of elbow caused by drug
  • Chronic tophaceous gout of hand caused by drug
  • Chronic tophaceous gout of hip caused by drug
  • Chronic tophaceous gout of knee caused by drug
  • Chronic tophaceous gout of multiple sites caused by drug
  • Chronic tophaceous gout of shoulder caused by drug
  • Chronic tophaceous gout of vertebra caused by drug
  • Chronic tophaceous gout of wrist caused by drug
  • Chronic toxic interstitial nephritis
  • Cicatrizing conjunctivitis
  • Cicatrizing conjunctivitis
  • Color changes during tooth formation
  • Conjugated hyperbilirubinemia
  • Conjunctival adrenochrome deposits
  • Conjunctival deposit due to drug
  • Conjunctivitis caused by drug
  • Conjunctivitis caused by drug
  • Conjunctivitis caused by drug
  • Conjunctivitis caused by drug
  • Constricted pupil
  • Constricted pupil
  • Cutaneous B-cell pseudolymphoma
  • Cutaneous inflammation due to cytotoxic therapy
  • Cutaneous T-cell pseudolymphoma
  • Cutaneous ulceration due to cytotoxic therapy
  • Cytopenia caused by drug
  • Dermatosis resulting from cytotoxic therapy
  • Dermatosis resulting from cytotoxic therapy
  • Dermatosis resulting from cytotoxic therapy
  • Dermatosis resulting from cytotoxic therapy
  • Dermatosis resulting from cytotoxic therapy
  • Diabetes mellitus induced by non-steroid drugs
  • Diabetes mellitus induced by non-steroid drugs without complication
  • Diarrhea due to drug
  • Diffuse alopecia
  • Dilated cardiomyopathy secondary to drug
  • Disorder of autonomic nervous system caused by drug
  • Disorder of autonomic nervous system caused by drug
  • Disorder of kidney due to drug induced diabetes mellitus
  • Disorder of kidney due to drug induced diabetes mellitus
  • Disorder of kidney due to drug induced diabetes mellitus
  • Disorder of kidney due to drug induced diabetes mellitus
  • Disorder of kidney due to drug induced diabetes mellitus
  • Disorder of kidney due to drug induced diabetes mellitus
  • Disorder of kidney due to drug induced diabetes mellitus
  • Disorder of nail color
  • Disorder of nail color
  • Disorder of vision due to secondary diabetes mellitus
  • Disturbance of hair cycle
  • Disturbance of hair cycle
  • Dizziness due to drug
  • Dizziness due to drug
  • Dose-related drug-induced neutropenia
  • Drug exanthem
  • Drug induced acquired central hypothyroidism
  • Drug induced anal ulceration
  • Drug induced central sleep apnea
  • Drug induced dysfunction of vestibular system
  • Drug induced lacrimal canalicular stenosis
  • Drug induced pulmonary fibrosis
  • Drug induced pulmonary fibrosis
  • Drug induced thrombotic thrombocytopenic purpura
  • Drug induction of cytochrome p450 CYP1A2 enzyme
  • Drug induction of cytochrome p450 CYP2C19 enzyme
  • Drug induction of cytochrome p450 CYP2C9 enzyme
  • Drug induction of cytochrome p450 CYP3A enzyme
  • Drug inhibition of cytochrome p450 CYP1A2 enzyme
  • Drug inhibition of cytochrome p450 CYP2C19 enzyme
  • Drug inhibition of cytochrome p450 CYP2C9 enzyme
  • Drug inhibition of cytochrome p450 CYP2D6 enzyme
  • Drug inhibition of cytochrome p450 CYP3A enzyme
  • Drug interaction with drug
  • Drug interaction with drug
  • Drug interaction with drug
  • Drug interaction with tobacco
  • Drug interaction with tobacco
  • Drug pigmentation
  • Drug pigmentation
  • Drug pigmentation
  • Drug pigmentation
  • Drug pigmentation
  • Drug reaction AND/OR intoxication specific to newborn
  • Drug reaction AND/OR intoxication specific to newborn
  • Drug reaction with eosinophilia and systemic symptoms
  • Drug related visual impairment
  • Drug tolerance
  • Drug-aggravated angioedema-urticaria
  • Drug-exacerbated psoriasis
  • Drug-induced acanthosis nigricans
  • Drug-induced acute cicatrizing conjunctivitis
  • Drug-induced acute dystonia
  • Drug-induced acute pancreatitis
  • Drug-induced acute pulmonary edema
  • Drug-induced adrenocortical insufficiency
  • Drug-induced adrenogenital disorder
  • Drug-induced anaphylaxis
  • Drug-induced androgenic alopecia
  • Drug-induced anetoderma
  • Drug-induced angioedema-urticaria
  • Drug-induced apnea
  • Drug-induced asthma
  • Drug-induced autoimmune hemolytic anemia
  • Drug-induced autoimmune reaction
  • Drug-induced autonomic dysfunction
  • Drug-induced bradycardia
  • Drug-induced bradycardia
  • Drug-induced bronchiolitis obliterans
  • Drug-induced bullous pemphigoid
  • Drug-induced cataract
  • Drug-induced cataract
  • Drug-induced central nervous system depression
  • Drug-induced cerebellar ataxia
  • Drug-induced cholestatic hepatitis
  • Drug-induced chorea
  • Drug-induced chronic hepatitis
  • Drug-induced chronic pancreatitis
  • Drug-induced cicatricial pemphigoid
  • Drug-induced cirrhosis of liver
  • Drug-induced coagulation inhibitor disorder
  • Drug-induced coagulation inhibitor disorder
  • Drug-induced coagulation inhibitor disorder
  • Drug-induced colitis
  • Drug-induced coma
  • Drug-induced constipation
  • Drug-induced corneal epithlelial deposit
  • Drug-induced cutis laxa
  • Drug-induced dermatomyositis
  • Drug-induced dermatosis
  • Drug-induced desquamation of skin
  • Drug-induced diabetes mellitus
  • Drug-induced disorder of cornea
  • Drug-induced disorder of cornea
  • Drug-induced disorder of cornea
  • Drug-induced disorder of cornea
  • Drug-induced disorder of cornea
  • Drug-induced disorder of cornea
  • Drug-induced disorder of cornea
  • Drug-induced disorder of cornea
  • Drug-induced disorder of liver
  • Drug-induced disorder of refraction AND/OR accommodation
  • Drug-induced disorder of refraction AND/OR accommodation
  • Drug-induced dyskinesia
  • Drug-induced dyskinesia
  • Drug-induced dyskinesia
  • Drug-induced dyskinesia
  • Drug-induced dyskinesia, acute onset
  • Drug-induced dystonia
  • Drug-induced dystonia
  • Drug-induced dystonia
  • Drug-induced dystonia
  • Drug-induced embolism
  • Drug-induced encephalopathy
  • Drug-induced enteritis of intestine
  • Drug-induced enteritis of intestine
  • Drug-induced enzyme deficiency anemia
  • Drug-induced eosinophilia
  • Drug-induced epidermolysis bullosa acquisita
  • Drug-induced epilepsy
  • Drug-induced erythema multiforme
  • Drug-induced erythema nodosum
  • Drug-induced erythromelalgia
  • Drug-induced feminization
  • Drug-induced fibrinolytic disorder
  • Drug-induced flushing
  • Drug-induced gastrointestinal disturbance
  • Drug-induced gingival hyperplasia
  • Drug-induced glaucoma
  • Drug-induced glaucoma
  • Drug-induced glaucoma
  • Drug-induced glaucoma
  • Drug-induced granulomatous mediastinitis
  • Drug-induced hair abnormality
  • Drug-induced hair abnormality
  • Drug-induced hair abnormality
  • Drug-induced hair abnormality
  • Drug-induced hair abnormality
  • Drug-induced hair abnormality
  • Drug-induced hair abnormality
  • Drug-induced hair color change
  • Drug-induced hepatic necrosis
  • Drug-induced hepatitis
  • Drug-induced hepatitis
  • Drug-induced hirsutism
  • Drug-induced hypergastrinemia
  • Drug-induced hyperglycemia
  • Drug-induced hyperhidrosis
  • Drug-induced hyperinsulinemia
  • Drug-induced hyperkalemia
  • Drug-induced hypermelanosis
  • Drug-induced hypermelanosis
  • Drug-induced hypermelanosis
  • Drug-induced hyperprolactinemia
  • Drug-induced hyperpyrexia
  • Drug-induced hypersomnia
  • Drug-induced hypertrichosis
  • Drug-induced hypocalcemia
  • Drug-induced hypoglycemia
  • Drug-induced hypoglycemia without coma
  • Drug-induced hypokalemia
  • Drug-induced hypomagnesemia
  • Drug-induced hypomelanosis
  • Drug-induced hyponatremia
  • Drug-induced hypoplasia of bone marrow
  • Drug-induced hypotension
  • Drug-induced ichthyosiform reaction
  • Drug-induced ileus
  • Drug-induced immune hemolytic anemia, hapten type
  • Drug-induced immune hemolytic anemia, immune complex type
  • Drug-induced immunodeficiency
  • Drug-induced interstitial lung disorder
  • Drug-induced interstitial lung disorder
  • Drug-induced interstitial lung disorder
  • Drug-induced interstitial lung disorder
  • Drug-induced intrahepatic cholestasis
  • Drug-induced keratoconjunctivitis
  • Drug-induced lesion
  • Drug-induced leukonychia
  • Drug-induced linear IgA disease
  • Drug-induced lupus erythematosus
  • Drug-induced lymphocytic vasculitis
  • Drug-induced malabsorption
  • Drug-induced male infertility
  • Drug-induced megacolon
  • Drug-induced melasma
  • Drug-induced membranous nephropathy
  • Drug-induced methemoglobinemia
  • Drug-induced mucositis
  • Drug-induced myasthenia
  • Drug-induced myoclonus
  • Drug-induced myopathy
  • Drug-induced nail abnormality
  • Drug-induced nail abnormality
  • Drug-induced nail abnormality
  • Drug-induced nail fragility
  • Drug-induced nail hypertrophy
  • Drug-induced nausea and vomiting
  • Drug-induced necrotizing vasculitis
  • Drug-induced neutropenia
  • Drug-induced neutrophilia
  • Drug-induced non autoimmune hemolytic anemia
  • Drug-induced obesity
  • Drug-induced oral condition
  • Drug-induced oral condition
  • Drug-induced oral condition
  • Drug-induced oral lichenoid reaction
  • Drug-induced oral pigmentation
  • Drug-induced oral ulceration
  • Drug-induced orofacial dyskinesia
  • Drug-induced osteoporosis
  • Drug-induced osteoporosis
  • Drug-induced osteoporosis with pathological fracture
  • Drug-induced palmoplantar pustular psoriasis
  • Drug-induced panniculitis
  • Drug-induced panniculitis
  • Drug-induced pellagra
  • Drug-induced pemphigus
  • Drug-induced pemphigus foliaceus
  • Drug-induced pemphigus vulgaris
  • Drug-induced peptic ulcer
  • Drug-induced pericarditis
  • Drug-induced persistent light reaction
  • Drug-induced photo-onycholysis
  • Drug-induced photosensitivity
  • Drug-induced photosensitivity
  • Drug-induced photosensitivity
  • Drug-induced pigmentation
  • Drug-induced pigmentation of cornea
  • Drug-induced pleural effusion
  • Drug-induced pleurisy
  • Drug-induced pneumonitis
  • Drug-induced pneumonitis
  • Drug-induced polymyositis
  • Drug-induced porphyria
  • Drug-induced pseudoporphyria
  • Drug-induced pseudoscleroderma
  • Drug-induced pseudoxanthoma elasticum
  • Drug-induced purpura
  • Drug-induced purpura
  • Drug-induced purpura
  • Drug-induced Raynaud's phenomenon
  • Drug-induced retinopathy
  • Drug-induced sideroblastic anemia
  • Drug-induced solar urticaria
  • Drug-induced Stevens-Johnson syndrome
  • Drug-induced stricture of esophagus
  • Drug-induced systemic lupus erythematosus
  • Drug-induced tardive dystonia
  • Drug-induced telangiectasia
  • Drug-induced thyroiditis
  • Drug-induced toxic pustuloderma
  • Drug-induced tubulointerstitial nephritis
  • Drug-induced ulceration
  • Drug-induced uveitis
  • Drug-induced virilization
  • Drug-induced xerostomia
  • Drug-related alopecia
  • Drug-related myocardial necrosis syndrome
  • Duodenal ulcer caused by drug
  • Duodenitis caused by drug
  • Dysfunction of vestibular system
  • Dysmotility of small intestine caused by drug
  • Effect of drug maladministration
  • Emollient adverse reaction
  • End stage renal disease on dialysis due to drug induced diabetes mellitus
  • End stage renal failure on dialysis
  • Endocrine alopecia
  • Endocrine drug side effect
  • Endocrine system complication of procedure
  • Endocrine system complication of procedure
  • Enlargement of alveolar ridge
  • ENT disorder monitoring status
  • ENT drug side effect
  • Epidermal fragility
  • Eruption due to drug
  • Erythroderma caused by drug
  • Erythromelalgia
  • Esophagitis medicamentosa
  • Exanthematous disorder
  • Excessive muscarinic activity
  • Exogenous pigmentation of oral mucosa
  • Extrinsic staining of teeth caused by drug
  • Factor IX inhibitor disorder
  • Factor V inhibitor disorder
  • Factor VIII inhibitor disorder
  • Falls
  • Falls caused by medication
  • Fat hypertrophy
  • Fat hypertrophy due to injected drug
  • Feminization
  • Fixed drug eruption
  • Fixed drug reaction
  • Fixed drug reaction
  • Fixed drug reaction
  • Fixed drug reaction affecting oral mucous membranes
  • Folate deficiency anemia, drug-induced
  • Gastric erosion
  • Gastric ulcer caused by drug
  • Gastric ulcer caused by drug
  • Gastric ulcer caused by drug
  • Gastric ulcer caused by drug
  • Gastritis medicamentosa
  • Gastritis medicamentosa
  • Gastroenteritis caused by drug
  • Generalized enamel hypoplasia associated with ingestion of drugs
  • Generalized rash
  • Generalized skin eruption caused by drug and medicament
  • Gingival disease due to drug
  • Gingival disease due to drug
  • Gingival disease due to drug
  • Gingival disease due to drug
  • Gingival enlargement exacerbated by drug
  • Gingivitis due to drug
  • Glaucoma of left eye caused by drug
  • Glaucoma of left eye caused by drug
  • Glaucoma of right eye caused by drug
  • Glaucoma of right eye caused by drug
  • Gout of ankle and/or foot caused by drug
  • Gout of ankle and/or foot caused by drug
  • Gout of ankle and/or foot caused by drug
  • Gout of elbow caused by drug
  • Gout of elbow caused by drug
  • Gout of elbow caused by drug
  • Gout of hand caused by drug
  • Gout of hand caused by drug
  • Gout of hand caused by drug
  • Gout of hip caused by drug
  • Gout of hip caused by drug
  • Gout of hip caused by drug
  • Gout of knee caused by drug
  • Gout of knee caused by drug
  • Gout of knee caused by drug
  • Gout of multiple sites caused by drug
  • Gout of shoulder caused by drug
  • Gout of shoulder caused by drug
  • Gout of shoulder caused by drug
  • Gout of vertebra caused by drug
  • Gout of vertebra caused by drug
  • Gout of vertebra caused by drug
  • Gout of wrist caused by drug
  • Gout of wrist caused by drug
  • Gout of wrist caused by drug
  • Gout secondary to drug
  • Granulomatous mediastinitis
  • Gray syndrome from chloramphenicol administration in newborn
  • Gyne. drug side effect
  • Gynecologic disorder monitoring status
  • Hapten type high affinity hemolytic anemia
  • Hapten type low affinity hemolytic anemia
  • Headache caused by drug
  • Headache caused by drug
  • Heart block due to drug
  • Hemolytic anemia due to drugs
  • Hemolytic anemia due to drugs
  • Hemolytic anemia due to drugs
  • Hemolytic anemia due to drugs
  • Hemolytic anemia due to drugs
  • Hemolytic anemia due to drugs
  • Hemolytic anemia due to drugs
  • Herbal medicine adverse reaction
  • High risk drug monitoring status
  • High risk drug side effect
  • Hirsutism
  • Homeopathic medicine adverse reaction
  • Hot flash due to medication
  • Hypercalcemia due to a drug
  • Hyperkalemia
  • Hyperosmolar coma due to diabetes mellitus
  • Hyperosmolar coma due to drug induced diabetes mellitus
  • Hyperosmolar coma due to secondary diabetes mellitus
  • Hyperosmolarity due to drug induced diabetes mellitus
  • Hyperosmolarity due to secondary diabetes mellitus
  • Hyperplasia of gingiva
  • Hyperpyrexia
  • Hypersensitivity disease of liver caused by drug
  • Hypersensitivity disease of liver caused by drug
  • Hypertension secondary to drug
  • Hypertrophy of nail
  • Hypocellular bone marrow
  • Hypophysectomy-induced hypopituitarism
  • Hypopituitarism caused by drug
  • Hyposecretion of salivary gland
  • Hypospermatogenesis
  • Hypothyroidism caused by drug
  • Iatrogenic adrenal insufficiency
  • Iatrogenic hypoglycemia
  • Iatrogenic hypopituitarism
  • Iatrogenic pituitary disorder
  • Iatrogenic thyroiditis
  • Idiosyncratic drug effect
  • Immune complex small vessel vasculitis caused by drug
  • Immune complex urticaria
  • Immunodeficiency caused by long term therapeutic use of drug
  • Impaired glucose tolerance associated with drugs
  • Increased gastrin secretion
  • Induced spermatogenic arrest
  • Infertility due to drug therapy
  • Inflammatory red colored lesion of internal part of mouth caused by drug
  • Insufficiency fracture
  • Interstitial pulmonary fibrosis due to inhalation of drug
  • Interstitial pulmonary fibrosis due to inhalation of substance
  • Intolerance to drug
  • Intractable headache caused by drug
  • Intraoperative floppy iris syndrome
  • Intraoperative floppy iris syndrome
  • Intraoperative floppy iris syndrome of left eye
  • Intraoperative floppy iris syndrome of right eye
  • Intravenous nutrition adverse reaction
  • Intravenous nutrition adverse reaction
  • Intravenous nutrition adverse reaction
  • Intravenous nutrition adverse reaction
  • Intrinsic staining of tooth - drug-induced
  • Irritant contact dermatitis due to drug in contact with skin
  • Keratopathy medicamentosa
  • Keratopathy of left eye caused by drug
  • Keratopathy of right eye caused by drug
  • Leukopenia caused by drug
  • Lichenoid drug eruption
  • Linear IgA dermatosis
  • Localized eruption of skin
  • Localized pustular psoriasis
  • Localized skin eruption caused by drug and medicament
  • Long QT syndrome caused by drug
  • Lubricant adverse reaction
  • Lyell syndrome
  • Lymphocyte count below reference range
  • Lymphocytic vasculitis of skin
  • Maculopapular drug eruption
  • Maculopapular eruption
  • Male pattern alopecia
  • Medication bezoar
  • Medication overuse headache
  • Medication side effects present
  • Medication-induced movement disorder
  • Medication-induced postural tremor
  • Megaloblastic anemia due to drugs
  • Megaloblastic anemia due to drugs
  • Motility disorder of small intestine
  • Multiple drug intolerant hypertension
  • Myelofibrosis
  • Myelofibrosis caused by drug
  • Myocarditis due to drug
  • Myotonia due to drug
  • Nail color change due to ingested drug
  • Nail dystrophy due to cytotoxic therapy
  • Nail fragility
  • Nausea and vomiting
  • Neonatal jaundice caused by drug transmitted from mother
  • Neonatal perforation of intestine caused by drug
  • Nephritis caused by drug
  • Nephropathy due to secondary diabetes mellitus
  • Nephropathy due to secondary diabetes mellitus
  • Nephropathy due to secondary diabetes mellitus
  • Nephropathy due to secondary diabetes mellitus
  • Nephropathy due to secondary diabetes mellitus
  • Nephropathy due to secondary diabetes mellitus
  • Nephropathy due to secondary diabetes mellitus
  • Neuroleptic-induced acute dystonia
  • Neurological disorder monitoring status
  • Neurological drug side effects
  • Neuropathy associated with hypoglycemia
  • Neutrophilia disorder
  • Neutrophilic eccrine hidradenitis
  • Neutrophilic eccrine hidradenitis due to cytotoxic therapy
  • Newborn drug intoxication
  • Newborn drug intoxication
  • Newborn drug reaction
  • Newborn drug reaction
  • Newborn drug reaction and intoxication
  • Niacin deficiency
  • Non dose-related adverse reaction to medication
  • Non dose-related drug-induced neutropenia
  • Non-allergic anaphylaxis caused by drug
  • Non-autoimmune hemolytic anemia
  • Non-diabetic hypoglycemia
  • Non-diabetic hypoglycemia
  • Non-melanin pigmentation due to drug
  • Non-pigmenting fixed drug eruption
  • Obstructive hyperbilirubinemia
  • Ocular cicatricial pemphigoid
  • Oligozoospermia
  • Oligozoospermia due to drug therapy
  • Onycholysis
  • Oral lichenoid reaction
  • Organic sleep disorder
  • Organic sleep related movement disorder
  • Orofacial dyskinesia
  • Osteomalacia secondary to drug
  • Osteonecrosis caused by drug
  • Osteonecrosis of ankle caused by drug
  • Osteonecrosis of carpus caused by drug
  • Osteonecrosis of femur caused by drug
  • Osteonecrosis of femur caused by drug
  • Osteonecrosis of fibula caused by drug
  • Osteonecrosis of finger caused by drug
  • Osteonecrosis of hand caused by drug
  • Osteonecrosis of hand caused by drug
  • Osteonecrosis of jaw
  • Osteonecrosis of jaw caused by drug
  • Osteonecrosis of pelvis caused by drug
  • Osteonecrosis of radius caused by drug
  • Osteonecrosis of shoulder caused by drug
  • Osteonecrosis of tibia caused by drug
  • Osteonecrosis of toe caused by drug
  • Osteopenia caused by drug
  • Ototoxicity
  • Ototoxicity - labyrinthine
  • Pain following administration of agent
  • Palpation thyroiditis
  • Parkinsonism due to drug
  • Pellagra
  • Pemphigus foliaceus
  • Pemphigus vulgaris
  • Persistent miosis
  • Persistent miosis
  • Pharmaceutical fluid or solution adverse reaction
  • Pharmacologic parasympathicotonic pupil
  • Pharmacological paralysis of accommodation
  • Photochemotherapy reaction
  • Photoonycholysis
  • Phototoxic drug eruption
  • Pill esophagitis
  • Pityriasis rosea-like drug eruption
  • Pleurothotonus
  • Polymyositis
  • Polyneuropathy due to diabetes mellitus
  • Polyneuropathy due to drug
  • Polyneuropathy due to drug induced diabetes mellitus
  • Polyneuropathy due to secondary diabetes mellitus
  • Posteruptive color change of tooth
  • Posteruptive color change of tooth
  • Posteruptive teeth staining
  • Posteruptive tooth staining due to drug
  • Posteruptive tooth staining due to drug
  • Pre-eruptive color change of tooth
  • Priapism
  • Priapism caused by drug
  • Pruritus caused by drug
  • Pseudolymphomatous eruption due to drug
  • Pseudolymphomatous eruption due to drug
  • Pseudolymphomatous eruption due to drug
  • Pseudoporphyria
  • Pseudoscleroderma due to cytotoxic therapy
  • Pseudoxanthoma elasticum
  • Psoriasiform drug eruption
  • Pulmonary arterial hypertension induced by drug
  • Pulmonary toxicity
  • Purpura due to drug-induced capillary damage
  • Purpura due to drug-induced coagulation abnormality
  • Pustular psoriasis of palm of hand
  • Pustular psoriasis of palms and soles
  • Pustular psoriasis of sole of foot
  • Radiation recall reaction due to cytotoxic therapy
  • Raynaud's phenomenon
  • Renal hypersensitivity caused by drug
  • Renal tubular defect
  • Renal tubular dysgenesis caused by drug
  • Restlessness
  • Restlessness
  • Retention of urine
  • Retention of urine caused by drug
  • Salivary dysfunction caries secondary to medication
  • Salivary dysfunction dental caries
  • Scleroderma-like secondary cutaneous sclerosis
  • Scleroderma-like secondary cutaneous sclerosis
  • Secondary acquired sideroblastic anemia
  • Secondary cerebellar degeneration
  • Secondary dental caries associated with local or systemic factors
  • Secondary hyperprolactinemia
  • Secondary hypomagnesemia
  • Serum sickness due to drug
  • Sinus bradycardia
  • Sinus bradycardia caused by drug
  • Skin peeling disorder
  • Sleep-related movement disorder caused by drug
  • Small vessel pulmonary hypertension
  • Small vessel vasculitis caused by immune complex
  • Solar urticaria
  • Solitary pulmonary hypertension
  • Spermatogenic arrest
  • Staining of teeth
  • Staining of teeth
  • Starch peritonitis
  • Stenosis of lacrimal canaliculi
  • Stevens Johnson syndrome AND toxic epidermal necrolysis overlap
  • Stevens-Johnson and toxic epidermal necrolysis overlap syndrome caused by drug
  • Stevens-Johnson syndrome
  • Stevens-Johnson syndrome, toxic epidermal necrolysis spectrum
  • Stevens-Johnson syndrome, toxic epidermal necrolysis spectrum
  • Stevens-Johnson syndrome, toxic epidermal necrolysis spectrum
  • Stomatitis medicamentosa
  • Strength of nails - finding
  • Stricture of esophagus
  • Subacute dyskinesia due to drug
  • Substance induction of cytochrome p450 CYP1A2 enzyme
  • Substance induction of cytochrome p450 CYP3A enzyme
  • Substance induction of cytochrome p450 enzyme
  • Substance induction of cytochrome p450 enzyme
  • Substance induction of cytochrome p450 enzyme
  • Substance induction of cytochrome p450 enzyme
  • Substance inhibition of cytochrome p450 CYP3A enzyme
  • Substance inhibition of cytochrome p450 enzyme
  • Substance inhibition of cytochrome p450 enzyme
  • Substance inhibition of cytochrome p450 enzyme
  • Substance inhibition of cytochrome p450 enzyme
  • Substance inhibition of cytochrome p450 enzyme
  • Sweet's disease due to drug
  • Swelling of gingival and edentulous alveolar ridge due to drug
  • Swollen gums
  • Sympathoparetic pupil caused by drug
  • Syringosquamous metaplasia due to cytotoxic therapy
  • Tardive dyskinesia
  • T-cell pseudolymphoma due to drug
  • Teeth staining due to drugs
  • Teeth staining due to drugs
  • Telogen effluvium
  • Telogen hair loss caused by drug
  • Thrombocytopenia due to drugs
  • Thrombophilia due to drug therapy
  • Thrombotic microangiopathy
  • Thrombotic thrombocytopenic purpura
  • Tic caused by drug
  • Torsades de pointe caused by drug
  • Torsades de pointes
  • Toxic adverse drug interaction with drug
  • Toxic disorder of refraction AND/OR accommodation
  • Toxic disorder of refraction AND/OR accommodation
  • Toxic enteritis of small intestine caused by drug
  • Toxic enteritis of small intestine caused by drug
  • Toxic epidermal necrolysis due to drug
  • Toxic keratoconjunctivitis
  • Toxic neuromuscular junction disorder
  • Toxic polyneuropathy
  • Tremor due to substance abuse
  • Ulcer of anus
  • Ulcer of esophagus due to ingestion of medicines
  • Ulcer of foot due to drug induced diabetes mellitus
  • Ultraviolet recall reaction due to cytotoxic therapy
  • Urticaria medicamentosa
  • Urticaria medicamentosa
  • Urticaria medicamentosa
  • Vasculitis secondary to drug
  • Ventricular tachycardia, polymorphic
  • Vertigo caused by drug
  • Vitamin B12 deficiency anemia caused by drug
  • Xerostomia

Diagnostic Related Group(s)

The code T50.905D is grouped in the following Diagnostic Related Group(s) (MS-DRG v39.0)
  • Aftercare With Cc/mcc (949)
  • Aftercare Without Cc/mcc (950)

Crosswalk Information

ICD-10 Code ICD-9 Code ICD-9 Description
T50.905D Right Arrow V58.89 Other specfied aftercare

This ICD-10 to ICD-9 data is based on the 2018 General Equivalency Mapping (GEM) files published by the Centers for Medicare & Medicaid Services (CMS) for informational purposes only. The data is not an ICD-10 conversion tool and doesn’t guarantee clinical accuracy.

Similar Codes

ICD-10 Code ICD-10 Description
T50 Poisoning by, adverse effect of and underdosing of diuretics and other and unspecified drugs, medicaments and biological substances
T50.0 Poisoning by, adverse effect of and underdosing of mineralocorticoids and their antagonists
T50.0X Poisoning by, adverse effect of and underdosing of mineralocorticoids and their antagonists
T50.0X1 Poisoning by mineralocorticoids and their antagonists, accidental (unintentional)
T50.0X1A Poisoning by mineralocorticoids and their antagonists, accidental (unintentional), initial encounter
T50.0X1D Poisoning by mineralocorticoids and their antagonists, accidental (unintentional), subsequent encounter
T50.0X1S Poisoning by mineralocorticoids and their antagonists, accidental (unintentional), sequela
T50.0X2 Poisoning by mineralocorticoids and their antagonists, intentional self-harm
T50.0X2A Poisoning by mineralocorticoids and their antagonists, intentional self-harm, initial encounter
T50.0X2D Poisoning by mineralocorticoids and their antagonists, intentional self-harm, subsequent encounter
T50.0X2S Poisoning by mineralocorticoids and their antagonists, intentional self-harm, sequela
T50.0X3 Poisoning by mineralocorticoids and their antagonists, assault
T50.0X3A Poisoning by mineralocorticoids and their antagonists, assault, initial encounter
T50.0X3D Poisoning by mineralocorticoids and their antagonists, assault, subsequent encounter
T50.0X3S Poisoning by mineralocorticoids and their antagonists, assault, sequela
T50.0X4 Poisoning by mineralocorticoids and their antagonists, undetermined
T50.0X4A Poisoning by mineralocorticoids and their antagonists, undetermined, initial encounter
T50.0X4D Poisoning by mineralocorticoids and their antagonists, undetermined, subsequent encounter
T50.0X4S Poisoning by mineralocorticoids and their antagonists, undetermined, sequela
T50.0X5 Adverse effect of mineralocorticoids and their antagonists
T50.0X5A Adverse effect of mineralocorticoids and their antagonists, initial encounter
T50.0X5D Adverse effect of mineralocorticoids and their antagonists, subsequent encounter
T50.0X5S Adverse effect of mineralocorticoids and their antagonists, sequela
T50.0X6 Underdosing of mineralocorticoids and their antagonists
T50.0X6A Underdosing of mineralocorticoids and their antagonists, initial encounter
T50.0X6D Underdosing of mineralocorticoids and their antagonists, subsequent encounter
T50.0X6S Underdosing of mineralocorticoids and their antagonists, sequela
T50.1 Poisoning by, adverse effect of and underdosing of loop [high-ceiling] diuretics
T50.1X Poisoning by, adverse effect of and underdosing of loop [high-ceiling] diuretics
T50.1X1 Poisoning by loop [high-ceiling] diuretics, accidental (unintentional)
T50.1X1A Poisoning by loop [high-ceiling] diuretics, accidental (unintentional), initial encounter
T50.1X1D Poisoning by loop [high-ceiling] diuretics, accidental (unintentional), subsequent encounter
T50.1X1S Poisoning by loop [high-ceiling] diuretics, accidental (unintentional), sequela
T50.1X2 Poisoning by loop [high-ceiling] diuretics, intentional self-harm
T50.1X2A Poisoning by loop [high-ceiling] diuretics, intentional self-harm, initial encounter
T50.1X2D Poisoning by loop [high-ceiling] diuretics, intentional self-harm, subsequent encounter
T50.1X2S Poisoning by loop [high-ceiling] diuretics, intentional self-harm, sequela
T50.1X3 Poisoning by loop [high-ceiling] diuretics, assault
T50.1X3A Poisoning by loop [high-ceiling] diuretics, assault, initial encounter
T50.1X3D Poisoning by loop [high-ceiling] diuretics, assault, subsequent encounter
T50.1X3S Poisoning by loop [high-ceiling] diuretics, assault, sequela
T50.1X4 Poisoning by loop [high-ceiling] diuretics, undetermined
T50.1X4A Poisoning by loop [high-ceiling] diuretics, undetermined, initial encounter
T50.1X4D Poisoning by loop [high-ceiling] diuretics, undetermined, subsequent encounter
T50.1X4S Poisoning by loop [high-ceiling] diuretics, undetermined, sequela
T50.1X5 Adverse effect of loop [high-ceiling] diuretics
T50.1X5A Adverse effect of loop [high-ceiling] diuretics, initial encounter
T50.1X5D Adverse effect of loop [high-ceiling] diuretics, subsequent encounter
T50.1X5S Adverse effect of loop [high-ceiling] diuretics, sequela
T50.1X6 Underdosing of loop [high-ceiling] diuretics
T50.1X6A Underdosing of loop [high-ceiling] diuretics, initial encounter
T50.1X6D Underdosing of loop [high-ceiling] diuretics, subsequent encounter
T50.1X6S Underdosing of loop [high-ceiling] diuretics, sequela
T50.2 Poisoning by, adverse effect of and underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
T50.2X Poisoning by, adverse effect of and underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
T50.2X1 Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional)
T50.2X1A Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional), initial encounter
T50.2X1D Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional), subsequent encounter
T50.2X1S Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional), sequela
T50.2X2 Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm
T50.2X2A Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, initial encounter
T50.2X2D Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, subsequent encounter
T50.2X2S Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, sequela
T50.2X3 Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault
T50.2X3A Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault, initial encounter
T50.2X3D Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault, subsequent encounter
T50.2X3S Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault, sequela
T50.2X4 Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined
T50.2X4A Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, initial encounter
T50.2X4D Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, subsequent encounter
T50.2X4S Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, sequela
T50.2X5 Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
T50.2X5A Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
T50.2X5D Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
T50.2X5S Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
T50.2X6 Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
T50.2X6A Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
T50.2X6D Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
T50.2X6S Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
T50.3 Poisoning by, adverse effect of and underdosing of electrolytic, caloric and water-balance agents
T50.3X Poisoning by, adverse effect of and underdosing of electrolytic, caloric and water-balance agents
T50.3X1 Poisoning by electrolytic, caloric and water-balance agents, accidental (unintentional)
T50.3X1A Poisoning by electrolytic, caloric and water-balance agents, accidental (unintentional), initial encounter
T50.3X1D Poisoning by electrolytic, caloric and water-balance agents, accidental (unintentional), subsequent encounter
T50.3X1S Poisoning by electrolytic, caloric and water-balance agents, accidental (unintentional), sequela
T50.3X2 Poisoning by electrolytic, caloric and water-balance agents, intentional self-harm
T50.3X2A Poisoning by electrolytic, caloric and water-balance agents, intentional self-harm, initial encounter
T50.3X2D Poisoning by electrolytic, caloric and water-balance agents, intentional self-harm, subsequent encounter
T50.3X2S Poisoning by electrolytic, caloric and water-balance agents, intentional self-harm, sequela
T50.3X3 Poisoning by electrolytic, caloric and water-balance agents, assault
T50.3X3A Poisoning by electrolytic, caloric and water-balance agents, assault, initial encounter
T50.3X3D Poisoning by electrolytic, caloric and water-balance agents, assault, subsequent encounter
T50.3X3S Poisoning by electrolytic, caloric and water-balance agents, assault, sequela
T50.3X4 Poisoning by electrolytic, caloric and water-balance agents, undetermined
T50.3X4A Poisoning by electrolytic, caloric and water-balance agents, undetermined, initial encounter
T50.3X4D Poisoning by electrolytic, caloric and water-balance agents, undetermined, subsequent encounter
T50.3X4S Poisoning by electrolytic, caloric and water-balance agents, undetermined, sequela
T50.3X5 Adverse effect of electrolytic, caloric and water-balance agents
T50.3X5A Adverse effect of electrolytic, caloric and water-balance agents, initial encounter
T50.3X5D Adverse effect of electrolytic, caloric and water-balance agents, subsequent encounter
T50.3X5S Adverse effect of electrolytic, caloric and water-balance agents, sequela
T50.3X6 Underdosing of electrolytic, caloric and water-balance agents
T50.3X6A Underdosing of electrolytic, caloric and water-balance agents, initial encounter
T50.3X6D Underdosing of electrolytic, caloric and water-balance agents, subsequent encounter
T50.3X6S Underdosing of electrolytic, caloric and water-balance agents, sequela
T50.4 Poisoning by, adverse effect of and underdosing of drugs affecting uric acid metabolism
T50.4X Poisoning by, adverse effect of and underdosing of drugs affecting uric acid metabolism
T50.4X1 Poisoning by drugs affecting uric acid metabolism, accidental (unintentional)
T50.4X1A Poisoning by drugs affecting uric acid metabolism, accidental (unintentional), initial encounter
T50.4X1D Poisoning by drugs affecting uric acid metabolism, accidental (unintentional), subsequent encounter
T50.4X1S Poisoning by drugs affecting uric acid metabolism, accidental (unintentional), sequela
T50.4X2 Poisoning by drugs affecting uric acid metabolism, intentional self-harm
T50.4X2A Poisoning by drugs affecting uric acid metabolism, intentional self-harm, initial encounter
T50.4X2D Poisoning by drugs affecting uric acid metabolism, intentional self-harm, subsequent encounter
T50.4X2S Poisoning by drugs affecting uric acid metabolism, intentional self-harm, sequela
T50.4X3 Poisoning by drugs affecting uric acid metabolism, assault
T50.4X3A Poisoning by drugs affecting uric acid metabolism, assault, initial encounter
T50.4X3D Poisoning by drugs affecting uric acid metabolism, assault, subsequent encounter
T50.4X3S Poisoning by drugs affecting uric acid metabolism, assault, sequela
T50.4X4 Poisoning by drugs affecting uric acid metabolism, undetermined
T50.4X4A Poisoning by drugs affecting uric acid metabolism, undetermined, initial encounter
T50.4X4D Poisoning by drugs affecting uric acid metabolism, undetermined, subsequent encounter
T50.4X4S Poisoning by drugs affecting uric acid metabolism, undetermined, sequela
T50.4X5 Adverse effect of drugs affecting uric acid metabolism
T50.4X5A Adverse effect of drugs affecting uric acid metabolism, initial encounter
T50.4X5D Adverse effect of drugs affecting uric acid metabolism, subsequent encounter
T50.4X5S Adverse effect of drugs affecting uric acid metabolism, sequela
T50.4X6 Underdosing of drugs affecting uric acid metabolism
T50.4X6A Underdosing of drugs affecting uric acid metabolism, initial encounter
T50.4X6D Underdosing of drugs affecting uric acid metabolism, subsequent encounter
T50.4X6S Underdosing of drugs affecting uric acid metabolism, sequela
T50.5 Poisoning by, adverse effect of and underdosing of appetite depressants
T50.5X Poisoning by, adverse effect of and underdosing of appetite depressants
T50.5X1 Poisoning by appetite depressants, accidental (unintentional)
T50.5X1A Poisoning by appetite depressants, accidental (unintentional), initial encounter
T50.5X1D Poisoning by appetite depressants, accidental (unintentional), subsequent encounter
T50.5X1S Poisoning by appetite depressants, accidental (unintentional), sequela
T50.5X2 Poisoning by appetite depressants, intentional self-harm
T50.5X2A Poisoning by appetite depressants, intentional self-harm, initial encounter
T50.5X2D Poisoning by appetite depressants, intentional self-harm, subsequent encounter
T50.5X2S Poisoning by appetite depressants, intentional self-harm, sequela
T50.5X3 Poisoning by appetite depressants, assault
T50.5X3A Poisoning by appetite depressants, assault, initial encounter
T50.5X3D Poisoning by appetite depressants, assault, subsequent encounter
T50.5X3S Poisoning by appetite depressants, assault, sequela
T50.5X4 Poisoning by appetite depressants, undetermined
T50.5X4A Poisoning by appetite depressants, undetermined, initial encounter
T50.5X4D Poisoning by appetite depressants, undetermined, subsequent encounter
T50.5X4S Poisoning by appetite depressants, undetermined, sequela
T50.5X5 Adverse effect of appetite depressants
T50.5X5A Adverse effect of appetite depressants, initial encounter
T50.5X5D Adverse effect of appetite depressants, subsequent encounter
T50.5X5S Adverse effect of appetite depressants, sequela
T50.5X6 Underdosing of appetite depressants
T50.5X6A Underdosing of appetite depressants, initial encounter
T50.5X6D Underdosing of appetite depressants, subsequent encounter
T50.5X6S Underdosing of appetite depressants, sequela
T50.6 Poisoning by, adverse effect of and underdosing of antidotes and chelating agents
T50.6X Poisoning by, adverse effect of and underdosing of antidotes and chelating agents
T50.6X1 Poisoning by antidotes and chelating agents, accidental (unintentional)
T50.6X1A Poisoning by antidotes and chelating agents, accidental (unintentional), initial encounter
T50.6X1D Poisoning by antidotes and chelating agents, accidental (unintentional), subsequent encounter
T50.6X1S Poisoning by antidotes and chelating agents, accidental (unintentional), sequela
T50.6X2 Poisoning by antidotes and chelating agents, intentional self-harm
T50.6X2A Poisoning by antidotes and chelating agents, intentional self-harm, initial encounter
T50.6X2D Poisoning by antidotes and chelating agents, intentional self-harm, subsequent encounter
T50.6X2S Poisoning by antidotes and chelating agents, intentional self-harm, sequela
T50.6X3 Poisoning by antidotes and chelating agents, assault
T50.6X3A Poisoning by antidotes and chelating agents, assault, initial encounter
T50.6X3D Poisoning by antidotes and chelating agents, assault, subsequent encounter
T50.6X3S Poisoning by antidotes and chelating agents, assault, sequela
T50.6X4 Poisoning by antidotes and chelating agents, undetermined
T50.6X4A Poisoning by antidotes and chelating agents, undetermined, initial encounter
T50.6X4D Poisoning by antidotes and chelating agents, undetermined, subsequent encounter
T50.6X4S Poisoning by antidotes and chelating agents, undetermined, sequela
T50.6X5 Adverse effect of antidotes and chelating agents
T50.6X5A Adverse effect of antidotes and chelating agents, initial encounter
T50.6X5D Adverse effect of antidotes and chelating agents, subsequent encounter
T50.6X5S Adverse effect of antidotes and chelating agents, sequela
T50.6X6 Underdosing of antidotes and chelating agents
T50.6X6A Underdosing of antidotes and chelating agents, initial encounter
T50.6X6D Underdosing of antidotes and chelating agents, subsequent encounter
T50.6X6S Underdosing of antidotes and chelating agents, sequela
T50.7 Poisoning by, adverse effect of and underdosing of analeptics and opioid receptor antagonists
T50.7X Poisoning by, adverse effect of and underdosing of analeptics and opioid receptor antagonists
T50.7X1 Poisoning by analeptics and opioid receptor antagonists, accidental (unintentional)
T50.7X1A Poisoning by analeptics and opioid receptor antagonists, accidental (unintentional), initial encounter
T50.7X1D Poisoning by analeptics and opioid receptor antagonists, accidental (unintentional), subsequent encounter
T50.7X1S Poisoning by analeptics and opioid receptor antagonists, accidental (unintentional), sequela
T50.7X2 Poisoning by analeptics and opioid receptor antagonists, intentional self-harm
T50.7X2A Poisoning by analeptics and opioid receptor antagonists, intentional self-harm, initial encounter
T50.7X2D Poisoning by analeptics and opioid receptor antagonists, intentional self-harm, subsequent encounter
T50.7X2S Poisoning by analeptics and opioid receptor antagonists, intentional self-harm, sequela
T50.7X3 Poisoning by analeptics and opioid receptor antagonists, assault
T50.7X3A Poisoning by analeptics and opioid receptor antagonists, assault, initial encounter
T50.7X3D Poisoning by analeptics and opioid receptor antagonists, assault, subsequent encounter
T50.7X3S Poisoning by analeptics and opioid receptor antagonists, assault, sequela
T50.7X4 Poisoning by analeptics and opioid receptor antagonists, undetermined
T50.7X4A Poisoning by analeptics and opioid receptor antagonists, undetermined, initial encounter
T50.7X4D Poisoning by analeptics and opioid receptor antagonists, undetermined, subsequent encounter
T50.7X4S Poisoning by analeptics and opioid receptor antagonists, undetermined, sequela
T50.7X5 Adverse effect of analeptics and opioid receptor antagonists
T50.7X5A Adverse effect of analeptics and opioid receptor antagonists, initial encounter
T50.7X5D Adverse effect of analeptics and opioid receptor antagonists, subsequent encounter
T50.7X5S Adverse effect of analeptics and opioid receptor antagonists, sequela
T50.7X6 Underdosing of analeptics and opioid receptor antagonists
T50.7X6A Underdosing of analeptics and opioid receptor antagonists, initial encounter
T50.7X6D Underdosing of analeptics and opioid receptor antagonists, subsequent encounter
T50.7X6S Underdosing of analeptics and opioid receptor antagonists, sequela
T50.8 Poisoning by, adverse effect of and underdosing of diagnostic agents
T50.8X Poisoning by, adverse effect of and underdosing of diagnostic agents
T50.8X1 Poisoning by diagnostic agents, accidental (unintentional)
T50.8X1A Poisoning by diagnostic agents, accidental (unintentional), initial encounter
T50.8X1D Poisoning by diagnostic agents, accidental (unintentional), subsequent encounter
T50.8X1S Poisoning by diagnostic agents, accidental (unintentional), sequela
T50.8X2 Poisoning by diagnostic agents, intentional self-harm
T50.8X2A Poisoning by diagnostic agents, intentional self-harm, initial encounter
T50.8X2D Poisoning by diagnostic agents, intentional self-harm, subsequent encounter
T50.8X2S Poisoning by diagnostic agents, intentional self-harm, sequela
T50.8X3 Poisoning by diagnostic agents, assault
T50.8X3A Poisoning by diagnostic agents, assault, initial encounter
T50.8X3D Poisoning by diagnostic agents, assault, subsequent encounter
T50.8X3S Poisoning by diagnostic agents, assault, sequela
T50.8X4 Poisoning by diagnostic agents, undetermined
T50.8X4A Poisoning by diagnostic agents, undetermined, initial encounter
T50.8X4D Poisoning by diagnostic agents, undetermined, subsequent encounter
T50.8X4S Poisoning by diagnostic agents, undetermined, sequela
T50.8X5 Adverse effect of diagnostic agents
T50.8X5A Adverse effect of diagnostic agents, initial encounter
T50.8X5D Adverse effect of diagnostic agents, subsequent encounter
T50.8X5S Adverse effect of diagnostic agents, sequela
T50.8X6 Underdosing of diagnostic agents
T50.8X6A Underdosing of diagnostic agents, initial encounter
T50.8X6D Underdosing of diagnostic agents, subsequent encounter
T50.8X6S Underdosing of diagnostic agents, sequela
T50.9 Poisoning by, adverse effect of and underdosing of other and unspecified drugs, medicaments and biological substances
T50.90 Poisoning by, adverse effect of and underdosing of unspecified drugs, medicaments and biological substances
T50.901 Poisoning by unspecified drugs, medicaments and biological substances, accidental (unintentional)
T50.901A Poisoning by unspecified drugs, medicaments and biological substances, accidental (unintentional), initial encounter
T50.901D Poisoning by unspecified drugs, medicaments and biological substances, accidental (unintentional), subsequent encounter
T50.901S Poisoning by unspecified drugs, medicaments and biological substances, accidental (unintentional), sequela
T50.902 Poisoning by unspecified drugs, medicaments and biological substances, intentional self-harm
T50.902A Poisoning by unspecified drugs, medicaments and biological substances, intentional self-harm, initial encounter
T50.902D Poisoning by unspecified drugs, medicaments and biological substances, intentional self-harm, subsequent encounter
T50.902S Poisoning by unspecified drugs, medicaments and biological substances, intentional self-harm, sequela
T50.903 Poisoning by unspecified drugs, medicaments and biological substances, assault
T50.903A Poisoning by unspecified drugs, medicaments and biological substances, assault, initial encounter
T50.903D Poisoning by unspecified drugs, medicaments and biological substances, assault, subsequent encounter
T50.903S Poisoning by unspecified drugs, medicaments and biological substances, assault, sequela
T50.904 Poisoning by unspecified drugs, medicaments and biological substances, undetermined
T50.904A Poisoning by unspecified drugs, medicaments and biological substances, undetermined, initial encounter
T50.904D Poisoning by unspecified drugs, medicaments and biological substances, undetermined, subsequent encounter
T50.904S Poisoning by unspecified drugs, medicaments and biological substances, undetermined, sequela
T50.905 Adverse effect of unspecified drugs, medicaments and biological substances
T50.905A Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter
T50.905S Adverse effect of unspecified drugs, medicaments and biological substances, sequela
T50.906 Underdosing of unspecified drugs, medicaments and biological substances
T50.906A Underdosing of unspecified drugs, medicaments and biological substances, initial encounter
T50.906D Underdosing of unspecified drugs, medicaments and biological substances, subsequent encounter
T50.906S Underdosing of unspecified drugs, medicaments and biological substances, sequela
T50.91 Poisoning by, adverse effect of and underdosing of multiple unspecified drugs, medicaments and biological substances
T50.911 Poisoning by multiple unspecified drugs, medicaments and biological substances, accidental (unintentional)
T50.911A Poisoning by multiple unspecified drugs, medicaments and biological substances, accidental (unintentional), initial encounter
T50.911D Poisoning by multiple unspecified drugs, medicaments and biological substances, accidental (unintentional), subsequent encounter
T50.911S Poisoning by multiple unspecified drugs, medicaments and biological substances, accidental (unintentional), sequela
T50.912 Poisoning by multiple unspecified drugs, medicaments and biological substances, intentional self-harm
T50.912A Poisoning by multiple unspecified drugs, medicaments and biological substances, intentional self-harm, initial encounter
T50.912D Poisoning by multiple unspecified drugs, medicaments and biological substances, intentional self-harm, subsequent encounter
T50.912S Poisoning by multiple unspecified drugs, medicaments and biological substances, intentional self-harm, sequela
T50.913 Poisoning by multiple unspecified drugs, medicaments and biological substances, assault
T50.913A Poisoning by multiple unspecified drugs, medicaments and biological substances, assault, initial encounter
T50.913D Poisoning by multiple unspecified drugs, medicaments and biological substances, assault, subsequent encounter
T50.913S Poisoning by multiple unspecified drugs, medicaments and biological substances, assault, sequela
T50.914 Poisoning by multiple unspecified drugs, medicaments and biological substances, undetermined
T50.914A Poisoning by multiple unspecified drugs, medicaments and biological substances, undetermined, initial encounter
T50.914D Poisoning by multiple unspecified drugs, medicaments and biological substances, undetermined, subsequent encounter
T50.914S Poisoning by multiple unspecified drugs, medicaments and biological substances, undetermined, sequela
T50.915 Adverse effect of multiple unspecified drugs, medicaments and biological substances
T50.915A Adverse effect of multiple unspecified drugs, medicaments and biological substances, initial encounter
T50.915D Adverse effect of multiple unspecified drugs, medicaments and biological substances, subsequent encounter
T50.915S Adverse effect of multiple unspecified drugs, medicaments and biological substances, sequela
T50.916 Underdosing of multiple unspecified drugs, medicaments and biological substances
T50.916A Underdosing of multiple unspecified drugs, medicaments and biological substances, initial encounter
T50.916D Underdosing of multiple unspecified drugs, medicaments and biological substances, subsequent encounter
T50.916S Underdosing of multiple unspecified drugs, medicaments and biological substances, sequela
T50.99 Poisoning by, adverse effect of and underdosing of other drugs, medicaments and biological substances
T50.991 Poisoning by other drugs, medicaments and biological substances, accidental (unintentional)
T50.991A Poisoning by other drugs, medicaments and biological substances, accidental (unintentional), initial encounter
T50.991D Poisoning by other drugs, medicaments and biological substances, accidental (unintentional), subsequent encounter
T50.991S Poisoning by other drugs, medicaments and biological substances, accidental (unintentional), sequela
T50.992 Poisoning by other drugs, medicaments and biological substances, intentional self-harm
T50.992A Poisoning by other drugs, medicaments and biological substances, intentional self-harm, initial encounter
T50.992D Poisoning by other drugs, medicaments and biological substances, intentional self-harm, subsequent encounter
T50.992S Poisoning by other drugs, medicaments and biological substances, intentional self-harm, sequela
T50.993 Poisoning by other drugs, medicaments and biological substances, assault
T50.993A Poisoning by other drugs, medicaments and biological substances, assault, initial encounter
T50.993D Poisoning by other drugs, medicaments and biological substances, assault, subsequent encounter
T50.993S Poisoning by other drugs, medicaments and biological substances, assault, sequela
T50.994 Poisoning by other drugs, medicaments and biological substances, undetermined
T50.994A Poisoning by other drugs, medicaments and biological substances, undetermined, initial encounter
T50.994D Poisoning by other drugs, medicaments and biological substances, undetermined, subsequent encounter
T50.994S Poisoning by other drugs, medicaments and biological substances, undetermined, sequela
T50.995 Adverse effect of other drugs, medicaments and biological substances
T50.995A Adverse effect of other drugs, medicaments and biological substances, initial encounter
T50.995D Adverse effect of other drugs, medicaments and biological substances, subsequent encounter
T50.995S Adverse effect of other drugs, medicaments and biological substances, sequela
T50.996 Underdosing of other drugs, medicaments and biological substances
T50.996A Underdosing of other drugs, medicaments and biological substances, initial encounter
T50.996D Underdosing of other drugs, medicaments and biological substances, subsequent encounter
T50.996S Underdosing of other drugs, medicaments and biological substances, sequela
T50.A Poisoning by, adverse effect of and underdosing of bacterial vaccines
T50.A1 Poisoning by, adverse effect of and underdosing of pertussis vaccine, including combinations with a pertussis component
T50.A11 Poisoning by pertussis vaccine, including combinations with a pertussis component, accidental (unintentional)
T50.A11A Poisoning by pertussis vaccine, including combinations with a pertussis component, accidental (unintentional), initial encounter
T50.A11D Poisoning by pertussis vaccine, including combinations with a pertussis component, accidental (unintentional), subsequent encounter
T50.A11S Poisoning by pertussis vaccine, including combinations with a pertussis component, accidental (unintentional), sequela
T50.A12 Poisoning by pertussis vaccine, including combinations with a pertussis component, intentional self-harm
T50.A12A Poisoning by pertussis vaccine, including combinations with a pertussis component, intentional self-harm, initial encounter
T50.A12D Poisoning by pertussis vaccine, including combinations with a pertussis component, intentional self-harm, subsequent encounter
T50.A12S Poisoning by pertussis vaccine, including combinations with a pertussis component, intentional self-harm, sequela
T50.A13 Poisoning by pertussis vaccine, including combinations with a pertussis component, assault
T50.A13A Poisoning by pertussis vaccine, including combinations with a pertussis component, assault, initial encounter
T50.A13D Poisoning by pertussis vaccine, including combinations with a pertussis component, assault, subsequent encounter
T50.A13S Poisoning by pertussis vaccine, including combinations with a pertussis component, assault, sequela
T50.A14 Poisoning by pertussis vaccine, including combinations with a pertussis component, undetermined
T50.A14A Poisoning by pertussis vaccine, including combinations with a pertussis component, undetermined, initial encounter
T50.A14D Poisoning by pertussis vaccine, including combinations with a pertussis component, undetermined, subsequent encounter
T50.A14S Poisoning by pertussis vaccine, including combinations with a pertussis component, undetermined, sequela
T50.A15 Adverse effect of pertussis vaccine, including combinations with a pertussis component
T50.A15A Adverse effect of pertussis vaccine, including combinations with a pertussis component, initial encounter
T50.A15D Adverse effect of pertussis vaccine, including combinations with a pertussis component, subsequent encounter
T50.A15S Adverse effect of pertussis vaccine, including combinations with a pertussis component, sequela
T50.A16 Underdosing of pertussis vaccine, including combinations with a pertussis component
T50.A16A Underdosing of pertussis vaccine, including combinations with a pertussis component, initial encounter
T50.A16D Underdosing of pertussis vaccine, including combinations with a pertussis component, subsequent encounter
T50.A16S Underdosing of pertussis vaccine, including combinations with a pertussis component, sequela
T50.A2 Poisoning by, adverse effect of and underdosing of mixed bacterial vaccines without a pertussis component
T50.A21 Poisoning by mixed bacterial vaccines without a pertussis component, accidental (unintentional)
T50.A21A Poisoning by mixed bacterial vaccines without a pertussis component, accidental (unintentional), initial encounter
T50.A21D Poisoning by mixed bacterial vaccines without a pertussis component, accidental (unintentional), subsequent encounter
T50.A21S Poisoning by mixed bacterial vaccines without a pertussis component, accidental (unintentional), sequela
T50.A22 Poisoning by mixed bacterial vaccines without a pertussis component, intentional self-harm
T50.A22A Poisoning by mixed bacterial vaccines without a pertussis component, intentional self-harm, initial encounter
T50.A22D Poisoning by mixed bacterial vaccines without a pertussis component, intentional self-harm, subsequent encounter
T50.A22S Poisoning by mixed bacterial vaccines without a pertussis component, intentional self-harm, sequela
T50.A23 Poisoning by mixed bacterial vaccines without a pertussis component, assault
T50.A23A Poisoning by mixed bacterial vaccines without a pertussis component, assault, initial encounter
T50.A23D Poisoning by mixed bacterial vaccines without a pertussis component, assault, subsequent encounter
T50.A23S Poisoning by mixed bacterial vaccines without a pertussis component, assault, sequela
T50.A24 Poisoning by mixed bacterial vaccines without a pertussis component, undetermined
T50.A24A Poisoning by mixed bacterial vaccines without a pertussis component, undetermined, initial encounter
T50.A24D Poisoning by mixed bacterial vaccines without a pertussis component, undetermined, subsequent encounter
T50.A24S Poisoning by mixed bacterial vaccines without a pertussis component, undetermined, sequela
T50.A25 Adverse effect of mixed bacterial vaccines without a pertussis component
T50.A25A Adverse effect of mixed bacterial vaccines without a pertussis component, initial encounter
T50.A25D Adverse effect of mixed bacterial vaccines without a pertussis component, subsequent encounter
T50.A25S Adverse effect of mixed bacterial vaccines without a pertussis component, sequela
T50.A26 Underdosing of mixed bacterial vaccines without a pertussis component
T50.A26A Underdosing of mixed bacterial vaccines without a pertussis component, initial encounter
T50.A26D Underdosing of mixed bacterial vaccines without a pertussis component, subsequent encounter
T50.A26S Underdosing of mixed bacterial vaccines without a pertussis component, sequela
T50.A9 Poisoning by, adverse effect of and underdosing of other bacterial vaccines
T50.A91 Poisoning by other bacterial vaccines, accidental (unintentional)
T50.A91A Poisoning by other bacterial vaccines, accidental (unintentional), initial encounter
T50.A91D Poisoning by other bacterial vaccines, accidental (unintentional), subsequent encounter
T50.A91S Poisoning by other bacterial vaccines, accidental (unintentional), sequela
T50.A92 Poisoning by other bacterial vaccines, intentional self-harm
T50.A92A Poisoning by other bacterial vaccines, intentional self-harm, initial encounter
T50.A92D Poisoning by other bacterial vaccines, intentional self-harm, subsequent encounter
T50.A92S Poisoning by other bacterial vaccines, intentional self-harm, sequela
T50.A93 Poisoning by other bacterial vaccines, assault
T50.A93A Poisoning by other bacterial vaccines, assault, initial encounter
T50.A93D Poisoning by other bacterial vaccines, assault, subsequent encounter
T50.A93S Poisoning by other bacterial vaccines, assault, sequela
T50.A94 Poisoning by other bacterial vaccines, undetermined
T50.A94A Poisoning by other bacterial vaccines, undetermined, initial encounter
T50.A94D Poisoning by other bacterial vaccines, undetermined, subsequent encounter
T50.A94S Poisoning by other bacterial vaccines, undetermined, sequela
T50.A95 Adverse effect of other bacterial vaccines
T50.A95A Adverse effect of other bacterial vaccines, initial encounter
T50.A95D Adverse effect of other bacterial vaccines, subsequent encounter
T50.A95S Adverse effect of other bacterial vaccines, sequela
T50.A96 Underdosing of other bacterial vaccines
T50.A96A Underdosing of other bacterial vaccines, initial encounter
T50.A96D Underdosing of other bacterial vaccines, subsequent encounter
T50.A96S Underdosing of other bacterial vaccines, sequela
T50.B Poisoning by, adverse effect of and underdosing of viral vaccines
T50.B1 Poisoning by, adverse effect of and underdosing of smallpox vaccines
T50.B11 Poisoning by smallpox vaccines, accidental (unintentional)
T50.B11A Poisoning by smallpox vaccines, accidental (unintentional), initial encounter
T50.B11D Poisoning by smallpox vaccines, accidental (unintentional), subsequent encounter
T50.B11S Poisoning by smallpox vaccines, accidental (unintentional), sequela
T50.B12 Poisoning by smallpox vaccines, intentional self-harm
T50.B12A Poisoning by smallpox vaccines, intentional self-harm, initial encounter
T50.B12D Poisoning by smallpox vaccines, intentional self-harm, subsequent encounter
T50.B12S Poisoning by smallpox vaccines, intentional self-harm, sequela
T50.B13 Poisoning by smallpox vaccines, assault
T50.B13A Poisoning by smallpox vaccines, assault, initial encounter
T50.B13D Poisoning by smallpox vaccines, assault, subsequent encounter
T50.B13S Poisoning by smallpox vaccines, assault, sequela
T50.B14 Poisoning by smallpox vaccines, undetermined
T50.B14A Poisoning by smallpox vaccines, undetermined, initial encounter
T50.B14D Poisoning by smallpox vaccines, undetermined, subsequent encounter
T50.B14S Poisoning by smallpox vaccines, undetermined, sequela
T50.B15 Adverse effect of smallpox vaccines
T50.B15A Adverse effect of smallpox vaccines, initial encounter
T50.B15D Adverse effect of smallpox vaccines, subsequent encounter
T50.B15S Adverse effect of smallpox vaccines, sequela
T50.B16 Underdosing of smallpox vaccines
T50.B16A Underdosing of smallpox vaccines, initial encounter
T50.B16D Underdosing of smallpox vaccines, subsequent encounter
T50.B16S Underdosing of smallpox vaccines, sequela
T50.B9 Poisoning by, adverse effect of and underdosing of other viral vaccines
T50.B91 Poisoning by other viral vaccines, accidental (unintentional)
T50.B91A Poisoning by other viral vaccines, accidental (unintentional), initial encounter
T50.B91D Poisoning by other viral vaccines, accidental (unintentional), subsequent encounter
T50.B91S Poisoning by other viral vaccines, accidental (unintentional), sequela
T50.B92 Poisoning by other viral vaccines, intentional self-harm
T50.B92A Poisoning by other viral vaccines, intentional self-harm, initial encounter
T50.B92D Poisoning by other viral vaccines, intentional self-harm, subsequent encounter
T50.B92S Poisoning by other viral vaccines, intentional self-harm, sequela
T50.B93 Poisoning by other viral vaccines, assault
T50.B93A Poisoning by other viral vaccines, assault, initial encounter
T50.B93D Poisoning by other viral vaccines, assault, subsequent encounter
T50.B93S Poisoning by other viral vaccines, assault, sequela
T50.B94 Poisoning by other viral vaccines, undetermined
T50.B94A Poisoning by other viral vaccines, undetermined, initial encounter
T50.B94D Poisoning by other viral vaccines, undetermined, subsequent encounter
T50.B94S Poisoning by other viral vaccines, undetermined, sequela
T50.B95 Adverse effect of other viral vaccines
T50.B95A Adverse effect of other viral vaccines, initial encounter
T50.B95D Adverse effect of other viral vaccines, subsequent encounter
T50.B95S Adverse effect of other viral vaccines, sequela
T50.B96 Underdosing of other viral vaccines
T50.B96A Underdosing of other viral vaccines, initial encounter
T50.B96D Underdosing of other viral vaccines, subsequent encounter
T50.B96S Underdosing of other viral vaccines, sequela
T50.Z Poisoning by, adverse effect of and underdosing of other vaccines and biological substances
T50.Z1 Poisoning by, adverse effect of and underdosing of immunoglobulin
T50.Z11 Poisoning by immunoglobulin, accidental (unintentional)
T50.Z11A Poisoning by immunoglobulin, accidental (unintentional), initial encounter
T50.Z11D Poisoning by immunoglobulin, accidental (unintentional), subsequent encounter
T50.Z11S Poisoning by immunoglobulin, accidental (unintentional), sequela
T50.Z12 Poisoning by immunoglobulin, intentional self-harm
T50.Z12A Poisoning by immunoglobulin, intentional self-harm, initial encounter
T50.Z12D Poisoning by immunoglobulin, intentional self-harm, subsequent encounter
T50.Z12S Poisoning by immunoglobulin, intentional self-harm, sequela
T50.Z13 Poisoning by immunoglobulin, assault
T50.Z13A Poisoning by immunoglobulin, assault, initial encounter
T50.Z13D Poisoning by immunoglobulin, assault, subsequent encounter
T50.Z13S Poisoning by immunoglobulin, assault, sequela
T50.Z14 Poisoning by immunoglobulin, undetermined
T50.Z14A Poisoning by immunoglobulin, undetermined, initial encounter
T50.Z14D Poisoning by immunoglobulin, undetermined, subsequent encounter
T50.Z14S Poisoning by immunoglobulin, undetermined, sequela
T50.Z15 Adverse effect of immunoglobulin
T50.Z15A Adverse effect of immunoglobulin, initial encounter
T50.Z15D Adverse effect of immunoglobulin, subsequent encounter
T50.Z15S Adverse effect of immunoglobulin, sequela
T50.Z16 Underdosing of immunoglobulin
T50.Z16A Underdosing of immunoglobulin, initial encounter
T50.Z16D Underdosing of immunoglobulin, subsequent encounter
T50.Z16S Underdosing of immunoglobulin, sequela
T50.Z9 Poisoning by, adverse effect of and underdosing of other vaccines and biological substances
T50.Z91 Poisoning by other vaccines and biological substances, accidental (unintentional)
T50.Z91A Poisoning by other vaccines and biological substances, accidental (unintentional), initial encounter
T50.Z91D Poisoning by other vaccines and biological substances, accidental (unintentional), subsequent encounter
T50.Z91S Poisoning by other vaccines and biological substances, accidental (unintentional), sequela
T50.Z92 Poisoning by other vaccines and biological substances, intentional self-harm
T50.Z92A Poisoning by other vaccines and biological substances, intentional self-harm, initial encounter
T50.Z92D Poisoning by other vaccines and biological substances, intentional self-harm, subsequent encounter
T50.Z92S Poisoning by other vaccines and biological substances, intentional self-harm, sequela
T50.Z93 Poisoning by other vaccines and biological substances, assault
T50.Z93A Poisoning by other vaccines and biological substances, assault, initial encounter
T50.Z93D Poisoning by other vaccines and biological substances, assault, subsequent encounter
T50.Z93S Poisoning by other vaccines and biological substances, assault, sequela
T50.Z94 Poisoning by other vaccines and biological substances, undetermined
T50.Z94A Poisoning by other vaccines and biological substances, undetermined, initial encounter
T50.Z94D Poisoning by other vaccines and biological substances, undetermined, subsequent encounter
T50.Z94S Poisoning by other vaccines and biological substances, undetermined, sequela
T50.Z95 Adverse effect of other vaccines and biological substances
T50.Z95A Adverse effect of other vaccines and biological substances, initial encounter
T50.Z95D Adverse effect of other vaccines and biological substances, subsequent encounter
T50.Z95S Adverse effect of other vaccines and biological substances, sequela
T50.Z96 Underdosing of other vaccines and biological substances
T50.Z96A Underdosing of other vaccines and biological substances, initial encounter
T50.Z96D Underdosing of other vaccines and biological substances, subsequent encounter
T50.Z96S Underdosing of other vaccines and biological substances, sequela


This page was last updated on: 10/1/2023